Celldex Therapeutics (CLDX) Financials: Revenue & Earnings

CLDX price $29.28 -0.87 -2.89%

Ticker
CLDX
Price
$29.28
Change
-0.87 -2.89%
Market cap ?
$2.30B
P/E ?
-6.77
Forward P/E ?
7.70
Dividend yield ?
0.00%
Beta ?
0.90
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
67860001274300095380003573000741800046510002357000688300070200001500000

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the…

Fair value

CLDX fair value $74.70. Price $29.28. Price is 61% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 397.96K. Growth 7.66%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.23% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 78.53M. Net debt -26.54M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CLDX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-1.02—722.64K
2026-08-06-0.94-1.0622.00K734.92K
2026-05-07-1.18-1.1515.00K795.36K
2026-02-25-1.22-1.00100.00K1.32M
2025-11-10-1.01-0.88—985.82K
2025-08-07-0.85-0.86730.00K1.03M
2025-05-08-0.81-0.75695.00K997.60K
2025-02-27-0.71-0.731.18M1.02M
2024-11-06-0.64-0.693.19M835.56K
2024-08-08-0.54-0.592.50M854.29K
2024-05-06-0.56-0.67200.00K809.00K
2024-02-26-0.83-0.764.13M1.44M
2023-11-02-0.81-0.671.52M583.33K
2023-08-08-0.65-0.65268.00K528.00K
2023-05-04-0.62-0.63967.00K410.00K
2023-02-28-0.56-0.591.61M264.00K
2022-11-09-0.57-0.57407.00K360.00K
2022-08-08-0.77-0.46163.00K400.00K
2022-05-05-0.49-0.46174.00K560.00K
2022-02-28-0.43-0.42333.00K1.04M
2021-11-09-0.39-0.35153.00K640.00K
2021-08-05-0.34-0.403.48M685.00K
2021-05-06-0.42-0.32685.00K600.00K
2021-03-29-0.26-0.373.79M600.00K
2020-11-05-0.36-0.34668.00K668.00K
2020-08-06-0.50-0.58236.00K273.76K
2020-05-06-0.73-0.702.73M2.65M
2020-03-26-0.64-0.90887.00K1.25M
2019-11-12-0.75-0.84546.00K611.52K
2019-08-07-0.84-1.17715.00K995.89K
2019-05-07-1.40-1.141.43M1.16M
2019-03-07-0.81-1.201.76M2.61M
2018-11-07-1.20-2.25941.00K3.53M
2018-08-08-1.65-2.102.76M3.51M
2018-05-10-12.60-2.554.07M978.74K
2018-03-07-0.45-3.453.46M28.53M
2017-11-07-3.00-3.603.92M5.19M
2017-08-08-3.45-3.753.83M4.54M
2017-05-09-4.20-4.201.53M1.56M
2017-03-14-4.50-5.101.87M2.09M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-25Lawver Teri LBuy90.00K$34.093.07M
2026-06-25Jimenez Freddy A.Buy93.00K$34.093.17M
2026-06-25Young Diane C.Buy57.00K$34.091.94M
2026-06-25Heath-Chiozzi MargoBuy95.00K$34.093.24M
2026-06-25Martin Samuel BatesBuy93.00K$34.093.17M
2026-06-25Cavanaugh SarahBuy95.00K$34.093.24M
2026-06-25Crowley ElizabethBuy100.00K$34.093.41M
2026-06-25PEPIN RONALDBuy20.00K$34.09681.80K
2026-06-25KELER TIBORBuy115.00K$34.093.92M
2026-06-25Marucci Anthony SBuy375.00K$34.0912.78M
2026-06-25Torres DeniceBuy26.00K$34.09886.34K
2026-06-25Jain RitaBuy26.00K$34.09886.34K
2026-06-25NEIL GARRY ARTHURBuy26.00K$34.09886.34K
2026-06-25Cohen CherylBuy26.00K$34.09886.34K
2026-06-25Brownlie Keith LBuy26.00K$34.09886.34K
2026-06-25MARINO JAMES JBuy26.00K$34.09886.34K
2026-06-25CONRAD HERBERT JBuy26.00K$34.09886.34K
2026-06-25PENNER HARRY JRBuy26.00K$34.09886.34K
2026-01-02Martin Samuel BatesSell4.82K$10.3850.00K
2026-01-02Martin Samuel BatesBuy4.82K$10.3850.00K
2025-12-15PEPIN RONALDBuy11.00K$2.7830.58K
2025-12-15PEPIN RONALDBuy8.33K$9.0275.13K
2025-12-15PEPIN RONALDSell8.33K$9.0275.13K
2025-12-15PEPIN RONALDSell11.00K$2.7830.58K
2025-12-04Jimenez Freddy A.Sell4.17K$29.09121.21K
2025-11-13Wright Richard M.Buy15.75K$22.48354.06K
2025-11-13Wright Richard M.Buy26.67K$10.38276.86K
2025-11-13Wright Richard M.Buy6.88K$9.0262.00K
2025-11-13Wright Richard M.Sell49.30K$24.001.18M
2025-11-13Wright Richard M.Sell15.75K$22.48354.06K
2025-11-13Wright Richard M.Sell26.67K$10.38276.86K
2025-11-13Wright Richard M.Sell6.88K$9.0262.00K
2025-11-10Lawver Teri LBuy100.00K$22.672.27M
2025-11-10Lawver Teri LOther0——
2025-08-13Jimenez Freddy A.Sell341$23.958.17K
2025-08-13Jimenez Freddy A.Sell430$25.4110.93K
2025-06-05Cavanaugh SarahBuy78.00K$19.531.52M
2025-06-05Crowley ElizabethBuy85.00K$19.531.66M
2025-06-05Heath-Chiozzi MargoBuy82.00K$19.531.60M
2025-06-05Jimenez Freddy A.Buy75.00K$19.531.46M
2025-06-05Martin Samuel BatesBuy81.00K$19.531.58M
2025-06-05PEPIN RONALDBuy20.00K$19.53390.60K
2025-06-05Young Diane C.Buy72.00K$19.531.41M
2025-06-05KELER TIBORBuy93.00K$19.531.82M
2025-06-05Marucci Anthony SBuy300.00K$19.535.86M
2025-06-05Torres DeniceBuy33.00K$19.53644.49K
2025-06-05Jain RitaBuy16.50K$19.53322.25K
2025-06-05NEIL GARRY ARTHURBuy16.50K$19.53322.25K
2025-06-05PENNER HARRY JRBuy16.50K$19.53322.25K
2025-06-05CONRAD HERBERT JBuy16.50K$19.53322.25K
2025-06-05MARINO JAMES JBuy16.50K$19.53322.25K
2025-06-05Brownlie Keith LBuy16.50K$19.53322.25K
2025-06-05Cohen CherylBuy16.50K$19.53322.25K
2025-06-05Torres DeniceOther0——
2024-11-18MARINO JAMES JSell10.50K——
2024-11-11Marucci Anthony SBuy11.50K$26.82308.43K
2024-06-14Martin Samuel BatesSell16.97K$10.38176.13K
2024-06-14Martin Samuel BatesBuy16.97K$10.38176.13K
2024-06-14Martin Samuel BatesBuy3.20K$9.0228.86K
2024-06-14Martin Samuel BatesSell17.17K$35.42608.31K
2024-06-14Martin Samuel BatesSell3.20K$9.0228.86K
2024-06-14Crowley ElizabethSell30.00K$10.38311.40K
2024-06-14Crowley ElizabethBuy30.00K$10.38311.40K
2024-06-14Crowley ElizabethSell30.00K$34.871.05M
2024-06-13Jimenez Freddy A.Buy75.00K$36.432.73M
2024-06-13Young Diane C.Buy72.00K$36.432.62M
2024-06-13Heath-Chiozzi MargoBuy82.00K$36.432.99M
2024-06-13Cavanaugh SarahBuy78.00K$36.432.84M
2024-06-13Crowley ElizabethBuy85.00K$36.433.10M
2024-06-13Wright Richard M.Buy65.00K$36.432.37M
2024-06-13PEPIN RONALDBuy20.00K$36.43728.60K
2024-06-13Martin Samuel BatesBuy81.00K$36.432.95M
2024-06-13KELER TIBORBuy93.00K$36.433.39M
2024-06-13Marucci Anthony SBuy300.00K$36.4310.93M
2024-06-13Jain RitaBuy16.50K$36.43601.10K
2024-06-13NEIL GARRY ARTHURBuy16.50K$36.43601.10K
2024-06-13Cohen CherylBuy16.50K$36.43601.10K
2024-06-13Brownlie Keith LBuy16.50K$36.43601.10K
2024-06-13MARINO JAMES JBuy16.50K$36.43601.10K
2024-06-13CONRAD HERBERT JBuy16.50K$36.43601.10K
2024-06-13Shoos Karen L.Buy16.50K$36.43601.10K
2024-06-13PENNER HARRY JRBuy16.50K$36.43601.10K
2024-06-11Young Diane C.Buy15.00K$2.7140.65K
2024-06-11Young Diane C.Sell15.00K$2.7140.65K
2024-06-07Crowley ElizabethSell7.50K$10.3877.85K
2024-06-07Crowley ElizabethBuy7.50K$9.0267.62K
2024-06-07Crowley ElizabethBuy7.50K$10.3877.85K
2024-06-07Crowley ElizabethSell15.00K$35.06525.87K
2024-06-07Crowley ElizabethSell7.50K$9.0267.62K
2024-06-07Young Diane C.Sell45.00K$35.261.59M
2024-06-05Jimenez Freddy A.Buy9.54K$10.3899.03K
2024-06-05Jimenez Freddy A.Sell9.54K$10.3899.03K
2024-06-03Heath-Chiozzi MargoBuy58.37K$10.38605.87K
2024-06-03Heath-Chiozzi MargoSell58.37K$10.38605.87K
2024-06-03Heath-Chiozzi MargoSell58.37K$33.651.96M
2024-06-03Heath-Chiozzi MargoBuy6.29K$9.0256.70K
2024-06-03Heath-Chiozzi MargoSell6.29K$9.0256.70K
2024-06-03Wright Richard M.Buy18.38K$22.48413.07K
2024-06-03Wright Richard M.Buy28.47K$28.00797.13K
2024-06-03Wright Richard M.Sell27.58K$33.53924.66K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 270, holders +36 vs prior quarter. Ownership 110.08%.

HolderSharesChangeChange %Value
WELLINGTON MANAGEMENT GROUP LLP9.54M983.20K+11.49%355.12M
BLACKROCK, INC.7.00M1.63M+30.40%260.56M
KYNAM CAPITAL MANAGEMENT, LP5.32M-517.66K-8.86%198.07M
PRICE T ROWE ASSOCIATES INC /MD/4.69M2.60M+124.57%174.34M
STATE STREET CORP3.90M1.10M+39.09%145.13M
FMR LLC3.72M-26.16K-0.70%138.53M
VANGUARD CAPITAL MANAGEMENT LLC3.46M503.94K+17.02%128.93M
DEEP TRACK CAPITAL, LP2.94M1.66M+128.91%109.37M
LOGOS GLOBAL MANAGEMENT LP2.10M1.65M+366.67%78.14M
GEODE CAPITAL MANAGEMENT, LLC2.02M334.15K+19.79%75.26M
EVERSEPT PARTNERS, LP1.79M-2.08K-0.12%66.45M
GOLDMAN SACHS GROUP INC1.62M626.93K+63.43%60.11M
COMMODORE CAPITAL LP1.35M-1.35M-49.94%50.23M
BELLEVUE GROUP AG1.20M00.00%44.65M
BAKER BROS. ADVISORS LP1.18M517.24K+77.74%44.00M
MILLENNIUM MANAGEMENT LLC1.17M-82.75K-6.60%43.56M
DIMENSIONAL FUND ADVISORS LP1.07M14.45K+1.36%39.96M
AMERICAN CENTURY COMPANIES INC1.04M186.09K+21.73%38.79M
EVENTIDE ASSET MANAGEMENT, LLC1.04M00.00%38.59M
NOVO HOLDINGS A/S1.02M-175.00K-14.58%38.14M
ELMIND CAPITAL, LP990.00K125.00K+14.45%36.84M
DRIEHAUS CAPITAL MANAGEMENT LLC989.44K989.44KNew36.82M
FISHER ASSET MANAGEMENT, LLC985.68K-27.97K-2.76%36.68M
PICTET ASSET MANAGEMENT HOLDING SA917.41K-6.29K-0.68%34.14M
FORESITE CAPITAL MANAGEMENT VI LLC879.71K563.80K+178.47%32.73M

Earnings and financials

Celldex Therapeutics, Inc. (CLDX) trades at $29.28, with a market cap of $2.30B and a trailing P/E of -6.77. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
67860001274300095380003573000741800046510002357000688300070200001500000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Celldex Therapeutics (CLDX) Financials: Revenue & Earnings

CLDX$29.28-0.87 -2.89%

$2.30B

Market Cap

-6.77

P/E

7.70

Forward P/E

—

Score

Price History